Sale!

Enhanced Liver Fibrosis (ELF) Panel Test

Original price was: $226.Current price is: $162.

-28%

The Enhanced Liver Fibrosis (ELF) Panel Test is a comprehensive blood test that assesses liver fibrosis using three specific biomarkers: hyaluronic acid, amino terminal propeptide of type III procollagen, and tissue inhibitor of metalloproteinase-1. This non-invasive test provides valuable information about liver scarring and fibrosis progression, helping detect liver damage before severe complications develop. The test is particularly beneficial for individuals with chronic liver conditions, elevated liver enzymes, or risk factors for liver disease. Results help guide treatment decisions and monitor disease progression. Available for $162 USD (regular price $226) at GGC DNA locations across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Enhanced Liver Fibrosis (ELF) Panel Test

Comprehensive Liver Health Assessment

The Enhanced Liver Fibrosis (ELF) Panel Test represents a significant advancement in liver disease diagnostics, offering a non-invasive method to assess liver fibrosis and scarring. Unlike traditional liver function tests that measure enzyme levels, the ELF panel specifically evaluates biomarkers directly associated with extracellular matrix remodeling and fibrogenesis processes in the liver. This sophisticated testing approach provides clinicians with crucial information about the extent of liver damage without requiring invasive liver biopsies.

What the ELF Panel Measures

The Enhanced Liver Fibrosis Panel measures three specific biomarkers that collectively provide a comprehensive assessment of liver fibrosis:

  • Hyaluronic Acid (HA): A glycosaminoglycan that accumulates during liver fibrosis and serves as a marker of hepatic stellate cell activation
  • Amino Terminal Propeptide of Type III Procollagen (PIIINP): Reflects collagen synthesis and deposition in the liver
  • Tissue Inhibitor of Metalloproteinase-1 (TIMP-1): Regulates extracellular matrix degradation and accumulates during fibrotic processes

These biomarkers are combined to generate an ELF score, which provides a quantitative assessment of liver fibrosis severity.

Who Should Consider This Test

The Enhanced Liver Fibrosis Panel is recommended for individuals experiencing:

  • Persistent fatigue and unexplained weakness
  • Elevated liver enzymes on routine blood tests
  • Chronic alcohol consumption or history of alcohol-related liver disease
  • Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH)
  • Viral hepatitis (Hepatitis B or C)
  • Family history of liver disease or genetic liver conditions
  • Unexplained abdominal discomfort or liver enlargement
  • Metabolic syndrome components including obesity and diabetes

Clinical Benefits of ELF Testing

Choosing the Enhanced Liver Fibrosis Panel offers several significant advantages:

  • Non-Invasive Alternative: Reduces the need for liver biopsy in many cases
  • Early Detection: Identifies liver fibrosis before advanced scarring develops
  • Treatment Monitoring: Tracks response to anti-fibrotic therapies
  • Risk Stratification: Helps determine appropriate management strategies
  • Prognostic Value: Provides information about disease progression risk
  • Cost-Effective: More affordable than repeated imaging studies or biopsies

Understanding Your Test Results

The ELF score interpretation follows established clinical guidelines:

  • Low Risk (ELF Score < 7.7): Indicates minimal or no significant fibrosis
  • Intermediate Risk (ELF Score 7.7-9.8): Suggests moderate fibrosis requiring monitoring
  • High Risk (ELF Score > 9.8): Indicates advanced fibrosis or cirrhosis requiring intervention

Your healthcare provider will interpret your results in the context of your medical history, physical examination findings, and other diagnostic tests to develop an appropriate management plan.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $162
Regular Price $226

Nationwide Testing Availability

GGC DNA provides Enhanced Liver Fibrosis Panel testing at our conveniently located facilities across the United States. We have branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art laboratories ensure accurate and timely results using the advanced Chemiluminescent Microparticle Immunoassay method.

Sample Requirements and Turnaround

Sample Type: 3 mL (1.5 mL minimum) serum from 1 SST tube
Shipping: Refrigerated or frozen
Fasting: Overnight fasting is mandatory
Turnaround Time: Samples accepted Monday/Thursday by 4 pm; Reports available next day

Take Control of Your Liver Health

Early detection of liver fibrosis can significantly impact treatment outcomes and prevent progression to more serious liver conditions. The Enhanced Liver Fibrosis Panel provides valuable insights that can guide your healthcare decisions and help preserve liver function.

Ready to assess your liver health? Book your Enhanced Liver Fibrosis Panel Test today by calling +1(267) 388-9828 or schedule your appointment online. Our experienced team is available to answer your questions and help you take the next step toward comprehensive liver health assessment.